Tag: FDA

FDA pulls OTC antibacterial soaps

Editor's Note The Food and Drug Administration (FDA) on September 2 issued a final rule saying that over-the-counter (OTC) antiseptic wash products containing active ingredients can no longer be marketed. The rule applies to products containing one or more of 19 ingredients, including the most commonly used triclosan and triclocarban.…

Read More

By: Judy Mathias
September 2, 2016
Share

FDA issues Safety Alert for Baxter’s Vascu-Guard patch

Editor's Note The Food and Drug Administration (FDA) on September 1 issued a Safety Alert for Baxter International’s (Deerfield, Illinois) Vascu-Guard Peripheral Vascular Patch. The FDA has received multiple adverse event reports associated with use of the Vascu-Guard patch during carotid endarterectomy, including intraoperative or postoperative bleeding and hematomas as…

Read More

By: Judy Mathias
September 1, 2016
Share

FDA advises testing of all donated blood, blood components for Zika

Editor's Note The Food and Drug Administration (FDA) on August 26 recommended testing of all donated blood and blood components for the Zika virus in the US and its territories. Because of much uncertainty about the nature and extent of Zika virus transmission, testing the entire blood supply will help…

Read More

By: Judy Mathias
August 29, 2016
Share

FDA issues Safety Alert for programmable syringe pumps

Editor's Note The Food and Drug Administration (FDA) on August 25 issued a Safety Alert for practitioners using programmable syringe pumps to infuse medications and solutions at low rates (eg, less than 5 mL/hour, and especially at less than 0.5 mL/hour). The FDA has received more than 300 reports that…

Read More

By: Judy Mathias
August 26, 2016
Share

FDA, device manufacturers make deal on user fees

Editor's Note The Food and Drug Administration and medical device manufacturers have made a deal on user fees companies pay to have the FDA review their products, the August 23 Mass Device reports. The Medical Device User Fee & Modernization Act IV will allow the FDA to collect nearly $1…

Read More

By: Judy Mathias
August 25, 2016
Share

FDA expands indication for two transcatheter aortic valves

Editor's Note The Food and Drug Administration (FDA) on August 18 approved an expanded indication for the Sapien XT and Sapien 3 transcatheter heart valves for patients with aortic stenosis. The new indication is for patients who are at intermediate risk for death or complications associated with open-heart surgery. Previously,…

Read More

By: Judy Mathias
August 24, 2016
Share

FDA: Sagent Pharmaceuticals recalls one lot of Oxacillin for Injection

Editor's Note The Food and Drug Administration (FDA) on August 19 announced the recall by Sagent Pharmaceuticals, Inc (Schaumburg, Illinois), of one lot of Oxacillin for Injection, USP, 10 g (NDC 25021-163-99) Lot OXT512 (Exp Date March 2017). The recall was initiated because of a user complaint of a vial…

Read More

By: Judy Mathias
August 22, 2016
Share

FDA issues safety alert on Custom Ultrasonics reprocessors

Editor's Note The Food and Drug Administration (FDA) on August 17 issued a Safety Alert on the System 83 Plus Automated Endoscope Reprocessors by Custom Ultrasonics (Warminster, Pennsylvania), recommending that healthcare facilities stop using them to reprocess duodenoscopes. The system may still be used for reprocessing endoscopes other than duodenoscopes.…

Read More

By: Judy Mathias
August 19, 2016
Share

FDA: Cook Medical recalls Roadrunner UniGlide Hydrophilic Wire Guides

Editor's Note The Food and Drug Administration (FDA) on August 15 announced the recall by Cook Medical (Bloomington, Indiana) of 8,750 units of its Roadrunner UniGlide Hydrophilic Wire Guides because of concerns about a potential contamination of the wires’ hydrophilic coating with glass particles. The wire guides are used in…

Read More

By: Judy Mathias
August 16, 2016
Share

FDA issues draft guidance on when to seek reapproval for medical devices

Editor's Note The Food and Drug Administration (FDA) on August 8 published draft guidance on when medical device manufacturers and software developers must obtain FDA clearance before making changes to existing products, the August 8 Modern Healthcare reports. The draft says if the “overall structure” of a device’s software is…

Read More

By: Judy Mathias
August 9, 2016
Share
Live chat by BoldChat